A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee
Status:
Withdrawn
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of intra-articular injection of resiniferatoxin
in patients with moderate to severe knee pain due to osteoarthritis.